METTL3-dependent RNA m6A dysregulation contributes to neurodegeneration in Alzheimer’s disease throu...
METTL3-dependent RNA m6A dysregulation contributes to neurodegeneration in Alzheimer’s disease through aberrant cell cycle events
About this item
Full title
Author / Creator
Publisher
London: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
London: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Background N6-methyladenosine (m.sup.6A) modification of RNA influences fundamental aspects of RNA metabolism and m.sup.6A dysregulation is implicated in various human diseases. In this study, we explored the potential role of RNA m.sup.6A modification in the pathogenesis of Alzheimer disease (AD). Methods We investigated the m.sup.6A modification...
Alternative Titles
Full title
METTL3-dependent RNA m6A dysregulation contributes to neurodegeneration in Alzheimer’s disease through aberrant cell cycle events
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_f66fe5d561794f0b98d55fb3390406cd
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f66fe5d561794f0b98d55fb3390406cd
Other Identifiers
ISSN
1750-1326
E-ISSN
1750-1326
DOI
10.1186/s13024-021-00484-x
